In a groundbreaking new study published in Nature Biotechnology, researchers have identified a novel gene that could revolutionize the way we treat cancer. The gene, named PRKAA2, has been found to be highly expressed in several types of cancer, including breast, lung, and colorectal cancers. The discovery of this gene could lead to the development of targeted therapies to treat these cancers. Additionally, the researchers suggest that PRKAA2 could be used as a predictive biomarker for cancer, allowing doctors to identify patients at risk and intervene sooner. This could potentially result in better outcomes for patients and improved treatments for cancer.

Read Full Article Here

source: Phys.org